BNTX Stock Analysis: Buy, Sell, or Hold?
BNTX - BioNTech SE American Depositary Share
$92.95
2.36 (2.61%)
▲
5d:
+2.04%
30d:
-4.72%
90d:
-4.71%
BUY
HIGH Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Aug 04, 2026
TODAY
Get Alerted When BNTX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: BNTX shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
✅ BUY SIGNAL: BNTX shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
In-depth Analysis How we analyze
Valuation Analysis: BNTX is currently trading at $92.94, which is considered fair relative to its 30-day fair value range of $90.42 to $93.85.
Technical Outlook: Technically, BNTX is in a uptrend. The price is approaching resistance at $94.41. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: BNTX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $123.20 (+36.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, BNTX is in a uptrend. The price is approaching resistance at $94.41. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: BNTX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $123.20 (+36.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$90.42 -
$93.85
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
86.8%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 36.0% below Wall St target ($123.20)
Trading Range Analysis
30-Day Trading Range
$90.42 -
$93.85
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$88.50
Resistance Level
$94.41
Current Trend
Uptrend
Technical data as of
Aug 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-20.93
Wall Street Target
$123.20
(+36.0%)
Revenue Growth (YoY)
-35.4%
Earnings Growth (YoY)
-43.2%
Profit Margin
-44.6%
Share & Embed Analysis
Last updated: August 03, 2026 2:51 PM ET
Data refreshes hourly during market hours. Next update: 3:51 PM
Data refreshes hourly during market hours. Next update: 3:51 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BNTX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Sierk Poetting
SELL
50000 shares
2026-04-22
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$34 | 55 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$123 | 59 HOLD |
|
RNA
Atrium Therapeutics, Inc… |
STRONG BUY
15 analysts |
$25 | 54 HOLD |
|
IRON
Disc Medicine Inc. |
STRONG BUY
11 analysts |
$102 | 60 HOLD |
|
ARWR
Arrowhead Pharmaceutical… |
STRONG BUY
13 analysts |
$108 | 60 BUY |
